Common Contracts

Collaboration and licensing agreement for GalXC RNAi technology platform to progress new drug targets

Collaboration and License Agreement • July 7th, 2024 • New York

• Contract Type
  Collaboration and License Agreement
• Filed
  July 7th, 2024
• Jurisdiction
  New York

This milestone triggers two single-digit multimillion-dollar milestone payments to Dicerna, which the Company expects to receive in the fourth quarter of 2021.